C07C 323/63
The carbon skeleton being further substituted by nitrogen atoms, not being part
Official title: the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
C07C323/63 (The carbon skeleton being further substituted by nitrogen atoms, not being part) appears on 148 US grants and 137 published applications in this corpus.
Search patents in C07C- Granted patents
- 148
- Published applications
- 137
- Assignees
- 99
- Inventors
- 449
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 2 |
| 2002 | 4 | 5 |
| 2003 | 6 | 5 |
| 2004 | 5 | 10 |
| 2005 | 6 | 6 |
| 2006 | 4 | 8 |
| 2007 | 2 | 7 |
| 2008 | 5 | 12 |
| 2009 | 5 | 8 |
| 2010 | 10 | 6 |
| 2011 | 6 | 11 |
| 2012 | 9 | 8 |
| 2013 | 8 | 6 |
| 2014 | 5 | 5 |
| 2015 | 2 | 7 |
| 2016 | 5 | 7 |
| 2017 | 8 | 3 |
| 2018 | 3 | 3 |
| 2019 | 2 | 3 |
| 2020 | 1 | 3 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 4 |
| 2024 | 2 | 2 |
| 2025 | 3 | 4 |
By publication year. Applications have been published since 2001.
Recent patents
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- Traceless reductively cleavable linker molecules for peptide purification19 Aug 2025US 12,391,727 B2Gyros Protein Technologies AB
- Traceless reductively cleavable linker molecules for peptide purification8 Apr 2025US 12,269,845 B2Gyros Protein Technologies AB
- Compound, composition, cured substance, optically anisotropic body, optical element, and light guide element6 Aug 2024US 12,054,660 B2FUJIFILM Corporation
- Compounds useful as potassium channel openers30 Jan 2024US 11,884,642 B2Acousia Therapeutics GmbH
- Phenylalanine-based lat1 inhibitors and uses thereof6 Nov 2025US 2025/0339388 A1Maxymune Therapeutics, Inc.
- Phenylalanine-based lat1 inhibitors and uses thereof16 Oct 2025US 2025/0319046 A1Maxymune Therapeutics, Inc.
- Pparg inverse agonists and uses thereof19 Jun 2025US 2025/0197357 A1Flare Therapeutics Inc.
- Pharmacological agents for treating ophthalmic diseases16 Jan 2025US 2025/0019352 A1Plex Pharmaceuticals, Inc.
- Palladium free processes for preparation of acrylate compounds31 Oct 2024US 2024/0360079 A1Amgen Inc.
Most cited
By later US patents
- Oxime sulfonates and the use thereof as latent sulfonic acids100US 6,004,724 ACiba Specialty Chemicals Corporation · 1999
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- Derivatization of non-natural amino acids and polypeptides61US 7,385,028 B2Ambrx, Inc. · 2008
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides60US 7,332,571 B2Ambrx, Inc. · 2008
- HIV protease inhibitors44US 5,863,950 AAgouron Pharmaceuticals, Inc. · 1999